Vertex Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
3,900
Employees3,900
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
3,900
Employees3,900

VRTX Key Statistics

Market cap
77.27B
Market cap77.27B
Price-Earnings ratio
23.76
Price-Earnings ratio23.76
Dividend yield
Dividend yield
Average volume
1.51M
Average volume1.51M
High today
$306.40
High today$306.40
Low today
$300.75
Low today$300.75
Open price
$304.92
Open price$304.92
Volume
1.62M
Volume1.62M
52 Week high
$325.19
52 Week high$325.19
52 Week low
$225.28
52 Week low$225.28

VRTX News

Investor's Business Daily 1d
Dow Jones' Rebound Fades; Tesla Revs Up On Record China Sales, Surprise EV Tax Credit

The Dow Jones Industrial Average faded Friday afternoon after rising off sessions lows. The blue chip index was down 0.4% at 1:30 p.m. ET. X The S&P 500 also...

Dow Jones' Rebound Fades; Tesla Revs Up On Record China Sales, Surprise EV Tax Credit
Yahoo Finance 3d
Vertex Pharmaceuticals Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Vertex Pharmaceuticals (VRTX) closed at $317.27 in the latest trading session, marking a -1.8% move from the prior day. This change lagged the S&P 500's 1.05% g...

Vertex Pharmaceuticals Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Benzinga 4d
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today - Benzinga

Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 12.93% on an annualized basis producing an average annual return of 20.63%. Cu...

$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today - Benzinga

Analyst ratings

66%

of 29 ratings
Buy
65.5%
Hold
34.5%
Sell
0%

VRTX Earnings

$0.00
$1.34
$2.67
$4.01
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
$3.53 per share
Estimated$3.53 per share
Actual
Available Feb 7, After Hours
ActualAvailable Feb 7, After Hours

More VRTX News

Investor's Business Daily 4d
This Clue Helps Spot The Best Stocks To Watch, Including These 11

Stock market history shows the best stocks to buy and watch often hail from the top-ranked industry groups. It's a telltale clue to help jump-start your search...

This Clue Helps Spot The Best Stocks To Watch, Including These 11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.